淋巴水肿治疗的进展  

Research Progress of Clinical Therapy for Lymphedema

作　　者：邓景成[1] 戴婷婷[1] 曹卫刚[1] 

机构地区：[1]上海交通大学医学院附属第九人民医院整复外科,上海市200011

出　　处：《组织工程与重建外科杂志》2016年第1期52-55,共4页Journal of Tissue Engineering and Reconstructive Surgery

基　　金：上海市教育委员会科研创新基金重点项目(No.13ZZ090)

摘　　要：淋巴水肿临床上并不罕见,其主要病因是淋巴管或淋巴结受到损害,导致淋巴液回流受阻,正常淋巴管一旦失去代偿能力,就会造成富含蛋白质的淋巴液在体内积聚,进而形成淋巴水肿。若不加以治疗,淋巴水肿可导致肢体进一步肿胀,皮下软组织纤维化、疼痛、感觉异常及感染等并发症。因此,早期发现淋巴水肿对其预后十分关键,早期治疗也可以明显降低淋巴水肿的并发症。本文就淋巴水肿治疗的进展进行综述。Lymphedema is not rarely seen clinically, and the most common etiology for the forming of lymphedema is the impaired flow of lymph fluid through the draining lymphatic vessels or lymph nodes. If the uninjured lymphatic vessels are unable to accommodate the increased lymphatic load, an abnormal accumulation of protein-rich lymph fluid develops in the tissues spaces. Lymphedema, without intervention, can lead to progressive swelling, fibrosis of the soft tissues, pain,paresthesias and infection. Therefore, early identification of the signs and symptoms of lymphedema is the key factor of the patients＇ prognosis, and complications can be minimized by early treatment. In this paper, progress of treatment in lymphedema was reviewed.

关 键 词：淋巴水肿 巴液引流 淋巴管再生 

分 类 号：R551.2[医药卫生—血液循环系统疾病]